Procoagulant Microvesicles in COVID-19 Patients: Possible Modulators of Inflammation and Prothrombotic Tendency

References

• Benvenuto D, Giovanetti M, Ciccozzi A, Spoto S, Angeletti S, Ciccozzi M. The 2019-new coronavirus epidemic: evidence for virus evolution. J Med Virol. 2020;92(4):455–459. doi:10.1002/jmv.25688
   PubMed Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-7
   PubMed Web of Science ®Google Scholar
• Che Mohd Nassir CMN, Hashim S, Wong KK, et al. COVID-19 infection and circulating microparticles-reviewing evidence as microthrombogenic risk factor for cerebral small vessel disease. Mol Neurobiol. 2021;58(8):4188–4215. doi:10.1007/s12035-021-02457-z
   PubMed Web of Science ®Google Scholar
• Akhter MS, Hamali HA, Mobarki AA, Rashid H, Oldenburg J, Biswas A. Sars-cov-2 infection: modulator of pulmonary embolism paradigm. J Clin Med. 2021;10(5):1–20. doi:10.3390/jcm10051064
   Web of Science ®Google Scholar
• Abid Hussein MN, Böing AN, Sturk A, Hau CM, Nieuwland R. Inhibition of microparticle release triggers endothelial cell apoptosis and detachment. Thromb Haemost. 2007;98(11):1096–1107. doi:10.1160/TH05-04-0231
   Web of Science ®Google Scholar
• Essayagh S, Brisset A-C, Terrisse A-D, et al. Microparticles from apoptotic vascular smooth muscle cells induce endothelial dysfunction, a phenomenon prevented by beta3-integrin antagonists. Thromb Haemost. 2005;94(4):853–858. doi:10.1160/TH04-12-0786
   Web of Science ®Google Scholar
• Rousseau M, Belleannee C, Duchez AC, et al. Detection and quantification of microparticles from different cellular lineages using flow cytometry. Evaluation of the impact of secreted phospholipase A2 on microparticle assessment. PLoS One. 2015;10(1):1–27. doi:10.1371/journal.pone.0116812
   Web of Science ®Google Scholar
• Iwai K, Minamisawa T, Suga K, Yajima Y, Shiba K. Isolation of human salivary extracellular vesicles by iodixanol density gradient ultracentrifugation and their characterizations. J Extracell Vesicles. 2016;5(1):30829. doi:10.3402/jev.v5.30829
   PubMed Web of Science ®Google Scholar
• Berckmans RJ, Sturk A, Van Tienen LM, Schaap MCL, Nieuwland R. Cell-derived vesicles exposing coagulant tissue factor in saliva. Blood. 2011;117(11):3172–3180. doi:10.1182/blood-2010-06-290460
   PubMed Web of Science ®Google Scholar
• Shill DD, Lansford KA, Hempel HK, Call JA, Murrow JR, Jenkins NT. Effect of exercise intensity on circulating microparticles in men and women. Exp Physiol. 2018;103(5):693–700. doi:10.1113/EP086644
   PubMed Web of Science ®Google Scholar
• Aharon A, Brenner B. Microparticles and pregnancy complications. Thromb Res. 2011;127(Suppl):S67–71. doi:10.1016/S0049-3848(11)70019-6
   PubMed Web of Science ®Google Scholar
• VanWijk MJ, Nieuwland R, Boer K, van der Post JAM, VanBavel E, Sturk A. Microparticle subpopulations are increased in preeclampsia: possible involvement in vascular dysfunction? Am J Obstet Gynecol. 2002;187(2):450–456. doi:10.1067/mob.2002.124279
   Web of Science ®Google Scholar
• Hamali H, Elhussein O, Jamil A, Hussain S, Alshraim M, Alshehri A. Elevated levels of pro‑coagulant microvesicles in children in‑steady state sickle cell disease. J Appl Hematol. 2015;6:115–118. doi:10.4103/1658-5127.165650
   Google Scholar
• Nieuwland R, Berckmans RJ, McGregor S, et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood. 2000;95(3):930–935. doi:10.1182/blood.V95.3.930.003k46_930_935
   PubMed Web of Science ®Google Scholar
• Burton JO, Hamali HA, Singh R, et al. Elevated levels of procoagulant plasma microvesicles in dialysis patients. PLoS One. 2013;8(8):e72663. doi:10.1371/journal.pone.0072663
   PubMed Web of Science ®Google Scholar
• Bidot L, Jy W, Bidot CJ, et al. Microparticle-mediated thrombin generation assay: increased activity in patients with recurrent thrombosis. J Thromb Haemost. 2008;6(6):913–919. doi:10.1111/j.1538-7836.2008.02963.x
   PubMed Web of Science ®Google Scholar
• Hamali HA, Mobarki AA, Akhter MS, et al. Elevated levels of procoagulant microvesicles in patients with dengue fever. Future Virol. 2020;15(10):701–706. doi:10.2217/fvl-2020-0202
   Web of Science ®Google Scholar
• Rosell A, Havervall S, von Meijenfeldt F, et al. Patients With COVID-19 have elevated levels of circulating extracellular vesicle tissue factor activity that is associated with severity and mortality-brief report. Arterioscler Thromb Vasc Biol. 2021;41(2):878–882. doi:10.1161/ATVBAHA.120.315547
   PubMed Web of Science ®Google Scholar
• Guervilly C, Bonifay A, Burtey S, et al. Dissemination of extreme levels of extracellular vesicles: tissue factor activity in patients with severe COVID-19. Blood Adv. 2021;5(3):628–634. doi:10.1182/bloodadvances.2020003308
   PubMed Web of Science ®Google Scholar
• Morel O, Marchandot B, Jesel L, et al. Microparticles in COVID-19 as a link between lung injury extension and thrombosis. ERJ Open Res. 2021;7(2):00954–02020. doi:10.1183/23120541.00954-2020
   Google Scholar
• Zahran AM, El-Badawy O, Ali WA, Mahran ZG, Mahran EE, Rayan A. Circulating microparticles and activated platelets as novel prognostic biomarkers in COVID-19; relation to cancer. PLoS One. 2021;16(2):1–17. doi:10.1371/journal.pone.0246806
   Web of Science ®Google Scholar
• Campbell RA, Hisada Y, Denorme F, et al. Comparison of the coagulopathies associated with COVID-19 and sepsis. Res Pract Thromb Haemost. 2021;5(4):e12525. doi:10.1002/rth2.12525
   PubMed Web of Science ®Google Scholar
• Balbi C, Burrello J, Bolis S, et al. Circulating extracellular vesicles are endowed with enhanced procoagulant activity in SARS-CoV-2 infection. EBioMedicine. 2021;67:103369. doi:10.1016/j.ebiom.2021.103369
   Web of Science ®Google Scholar
• Krishnamachary B, Cook C, Kumar A, Spikes L, Chalise P, Dhillon NK. Extracellular vesicle-mediated endothelial apoptosis and EV-associated proteins correlate with COVID-19 disease severity. J Extracell Vesicles. 2021;10(9):e12117. doi:10.1002/jev2.12117
   Web of Science ®Google Scholar
• Zwaal RFA, Comfurius P, Bevers EM. Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci. 2005;62(9):971–988. doi:10.1007/s00018-005-4527-3
   PubMed Web of Science ®Google Scholar
• Wolberg AS, Monroe DM, Roberts HR, Hoffman MR. Tissue factor de-encryption: ionophore treatment induces changes in tissue factor activity by phosphatidylserine-dependent and -independent mechanisms. Blood Coagul Fibrinolysis. 1999;10(4):201–210. doi:10.1097/00001721-199906000-00007
   PubMed Web of Science ®Google Scholar
• Sinauridze EI, Kireev DA, Popenko NY, et al. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost. 2007;97:425–434. doi:10.1160/TH06-06-0313
   PubMed Web of Science ®Google Scholar
• Berckmans RJ, Nieuwland R, Böing AN, Romijn FP, Hack CE, Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost. 2001;85(4):639–646. doi:10.1055/s-0037-1615646
   PubMed Web of Science ®Google Scholar
• Pozdnyakova O, Connell NT, Battinelli EM, Connors JM, Fell G, Kim AS. Clinical significance of CBC and WBC morphology in the diagnosis and clinical course of COVID-19 infection. Am J Clin Pathol. 2021;155(3):364–375. doi:10.1093/ajcp/aqaa231
   PubMed Web of Science ®Google Scholar
• Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620–2629. doi:10.1172/JCI137244
   PubMed Web of Science ®Google Scholar
• Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–847. doi:10.1111/jth.14768
   PubMed Web of Science ®Google Scholar
• Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383(2):120–128. doi:10.1056/NEJMoa2015432
   PubMed Web of Science ®Google Scholar
• Nieri D, Neri T, Petrini S, Vagaggini B, Paggiaro P, Celi A. Cell-derived microparticles and the lung. Eur Respir Rev. 2016;25(141):266–277. doi:10.1183/16000617.0009-2016
   Web of Science ®Google Scholar
• Joop K, Berckmans RJ, Nieuwland R, et al. Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost. 2001;85(5):810–820. doi:10.1055/s-0037-1615753
   Web of Science ®Google Scholar
• Daniel L, Fakhouri F, Joly D, et al. Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis. Kidney Int. 2006;69(8):1416–1423. doi:10.1038/sj.ki.5000306
   PubMed Web of Science ®Google Scholar
• von Meijenfeldt FA, Havervall S, Adelmeijer J, et al. Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge. Blood Adv. 2021;5(3):756–759. doi:10.1182/bloodadvances.2020003968
   PubMed Web of Science ®Google Scholar
• Barry OP, Pratico D, Lawson JA, FitzGerald GA. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest. 1997;99(9):2118–2127. doi:10.1172/JCI119385
   PubMed Web of Science ®Google Scholar
• Nomura S, Tandon NN, Nakamura T, Cone J, Fukuhara S, Kambayashi J. High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells. Atherosclerosis. 2001;158(2):277–287. doi:10.1016/s0021-9150(01)00433-6
   PubMed Web of Science ®Google Scholar
• Mesri M, Altieri DC. Endothelial cell activation by leukocyte microparticles. J Immunol. 1998;161(8):4382–4387.
   PubMed Web of Science ®Google Scholar
• Mause SF, von Hundelshausen P, Zernecke A, Koenen RR, Weber C. Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol. 2005;25(7):1512–1518. doi:10.1161/01.ATV.0000170133.43608.37
   PubMed Web of Science ®Google Scholar
• Gordon C, Gudi K, Krause A, et al. Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers. Am J Respir Crit Care Med. 2011;184(2):224–232. doi:10.1164/rccm.201012-2061OC
   PubMed Web of Science ®Google Scholar
• Bakouboula B, Morel O, Faure A, et al. Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension. Am J Respir Crit Care Med. 2008;177(5):536–543. doi:10.1164/rccm.200706-840OC
   Web of Science ®Google Scholar
• Abbas M, Jesel L, Auger C, et al. Endothelial microparticles from acute coronary syndrome patients induce premature coronary artery endothelial cell aging and thrombogenicity: role of the Ang II/AT1 receptor/NADPH oxidase-mediated activation of MAPKs and PI3-Kinase pathways. Circulation. 2017;135(3):280–296. doi:10.1161/CIRCULATIONAHA.116.017513
   Web of Science ®Google Scholar
• Takei Y, Yamada M, Saito K, et al. Increase in circulating ACE-positive endothelial microparticles during acute lung injury. Eur Respir J. 2019;54(4):1801188. doi:10.1183/13993003.01188-2018
   PubMed Web of Science ®Google Scholar
• Dalan R, Boehm BO. Thrombosis post COVID-19 vaccinations: potential link to ACE pathways. Thromb Res. 2021;206:137–138. doi:10.1016/j.thromres.2021.08.018
   Web of Science ®Google Scholar
• Mackman N, Tilley RE, Key NS. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol. 2007;27(8):1687–1693. doi:10.1161/ATVBAHA.107.141911
   PubMed Web of Science ®Google Scholar
• Giesen PLA, Rauch U, Bohrmann B, et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA. 1999;96(5):2311–2315. doi:10.1073/pnas.96.5.2311
   PubMed Web of Science ®Google Scholar
• Szotowski B, Antoniak S, Poller W, Schultheiss HP, Rauch U. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res. 2005;96(12):1233–1239. doi:10.1161/01.RES.0000171805.24799.fa
   PubMed Web of Science ®Google Scholar
• Bogdanov VY, Versteeg HH. Soluble tissue factor in the 21st Century: definitions, biochemistry, and pathophysiological role in thrombus formation. Semin Thromb Hemost. 2015;41(7):700–707. doi:10.1055/s-0035-1556049
   Web of Science ®Google Scholar
• Subrahmanian S, Borczuk A, Salvatore S, et al. Tissue factor upregulation is associated with SARS-CoV-2 in the lungs of COVID-19 patients. J Thromb Haemost. 2021;19(9):2268–2274. doi:10.1111/jth.15451
   Web of Science ®Google Scholar
• Nomura S, Shouzu A, Omoto S, Nishikawa M, Iwasaka T. Effects of losartan and simvastatin on monocyte-derived microparticles in hypertensive patients with and without type 2 diabetes mellitus. Clin Appl Thromb. 2004;10(2):133–141. doi:10.1177/107602960401000203
   PubMed Web of Science ®Google Scholar
• Lee YJ, Jy W, Horstman LL, et al. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. Thromb Res. 1993;72(4):295–304. doi:10.1016/0049-3848(93)90138-e
   PubMed Web of Science ®Google Scholar
• Wang T, Du Z, Zhu F, et al. Comorbidities and multi-organ injuries in the treatment of COVID-19. Lancet. 2020;395(10228):E52. doi:10.1016/S0140-6736(20)30558-4
   PubMed Web of Science ®Google Scholar
• Kerboua KE. NLR: a cost-effective nomogram to guide therapeutic interventions in COVID-19. Immunol Invest. 2021;50(1):92–100. doi:10.1080/08820139.2020.1773850
   PubMed Web of Science ®Google Scholar
• Liu J, Liu Y, Xiang P, et al. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med. 2020;18(1):1–12. doi:10.1186/s12967-020-02374-0
   PubMed Web of Science ®Google Scholar
• Ozcelik N, Ozyurt S, Yilmaz Kara B, Gumus A, Sahin U. The value of the platelet count and platelet indices in differentiation of COVID-19 and influenza pneumonia. J Med Virol. 2021;93(4):2221–2226. doi:10.1002/jmv.26645
   PubMed Web of Science ®Google Scholar
• Huang Z, Fu Z, Huang W, Huang K. Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: a meta-analysis. Am J Emerg Med. 2020;38(3):641–647. doi:10.1016/j.ajem.2019.10.023
   PubMed Web of Science ®Google Scholar
• Templeton AJ, Mcnamara MG, Šeruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. JNCI. 2014;106(6). doi:10.1093/jnci/dju124
   Google Scholar
• Mobarki AA, Dobie G, Saboor M, et al. MPR and NLR as prognostic markers in ICU-admitted patients with covid-19 in Jazan, Saudi Arabia. Infect Drug Resist. 2021;14:4859–4864. doi:10.2147/IDR.S342259
   PubMed Web of Science ®Google Scholar
• Zeng Z, Feng S, Chen G, Wu J. Predictive value of the neutrophil to lymphocyte ratio for disease deterioration and serious adverse outcomes in patients with COVID-19: a prospective cohort study. BMC Infect Dis. 2021;21(1):80. doi:10.1186/s12879-021-05796-3
   PubMed Web of Science ®Google Scholar
• Tatum D, Taghavi S, Houghton A, Stover J, Toraih E, Duchesne J. Neutrophil-to-lymphocyte ratio and outcomes in Louisiana COVID-19 patients. Shock. 2020;54(5):652–658. doi:10.1097/SHK.0000000000001585
   PubMed Web of Science ®Google Scholar
• Li X, Liu C, Mao Z, et al. Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis. Crit Care. 2020;24(1):647. doi:10.1186/s13054-020-03374-8
   PubMed Web of Science ®Google Scholar
• Sayed AA, Allam AA, Sayed AI, Alraey MA, Joseph MV. The use of neutrophil-to-lymphocyte ratio (NLR) as a marker for COVID-19 infection in Saudi Arabia. Saudi Med J. 2021;42(4):370LP- 376. doi:10.15537/smj.2021.42.4.20200818
   Web of Science ®Google Scholar
• Yang A-P, Liu J-P, Tao W-Q, Li H-M. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol. 2020;84:106504. doi:10.1016/j.intimp.2020.106504
   PubMed Web of Science ®Google Scholar